ID   FS-1 [Human leukemia]
AC   CVCL_2907
SY   FS-A
DR   BioSample; SAMN03472797
DR   JCRB; IFO50477
DR   Wikidata; Q54835184
RX   PubMed=8724543;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=FS-1
CC   Population: Japanese.
CC   Doubling time: ~7 days (PubMed=8724543).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): JCRB=IFO50477
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
RX   PubMed=8724543; DOI=10.3109/10428199609051743;
RA   Kato, Hidefumi
RA   Emi, Nobuhiko
RA   Tanimoto, Mitsune
RA   Saito, Hidehiko
RT   "Establishment and characterization of a novel human bone marrow
RT   stromal cell line, FS-1.";
RL   Leuk. Lymphoma 22:153-161(1996).
//